ARTICLE | Company News

BioDelivery sales and marketing update

December 6, 2010 8:00 AM UTC

BioDelivery said that Onsolis BEMA fentanyl manufacturing has resumed after a voluntary halt at Aveva Drug Delivery Systems (Miramar, Florida), the contract manufacturer of the drug. The shut down, which was announced in BioDelivery's 3Q10 earnings, was due to FDA concern involving other undisclosed products manufactured at the site. The company anticipates a March launch of Onsolis in Canada. The company said there has been a sufficient supply on hand in U.S. to continue sales without disruption. ...